Literature DB >> 6656991

Purine and pyrimidine base and nucleoside concentrations in human cerebrospinal fluid and plasma.

J T Eells, R Spector.   

Abstract

Purine and pyrimidine base and nucleoside levels were determined in adult human lumbar (CSF) and plasma by reversed-phase high performance liquid chromatography (HPLC). Guanine, thymine, cytosine and uracil were not detectable (less than 0.1 microM) in human CSF or plasma. Adenine was detectable in plasma (0.3 microM) but was not found in CSF (less than 0.2 microM). Hypoxanthine and xanthine levels in CSF were each approximately 2.5 microM. Plasma levels of hypoxanthine and xanthine were considerably lower (0.4-0.6 microM). Purine and pyrimidine ribonucleosides in human CSF were less than or equal to 0.2 microM with the exception of uridine which was present at concentrations of 2-3 microM. Although low concentrations of thymidine and deoxyuridine (0.2 microM) were present in human plasma, purine and pyrimidine deoxyribonucleosides were less than 0.1 microM in human lumbar CSF.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6656991     DOI: 10.1007/BF00965000

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  21 in total

1.  Determination of inosine and adenosine in human plasma using high-performance liquid chromatography and a boronate affinity gel.

Authors:  E H Pfadenhauer; S D Tong
Journal:  J Chromatogr       Date:  1979-04-11

2.  Cerebrospinal fluid concentrations of hypoxanthine, xanthine, uridine and inosine: high concentrations of the ATP metabolite, hypoxanthine, after hypoxia.

Authors:  R A Harkness; R J Lund
Journal:  J Clin Pathol       Date:  1983-01       Impact factor: 3.411

3.  Nucleoside transport in choroid plexus: mechanism and specificity.

Authors:  R Spector
Journal:  Arch Biochem Biophys       Date:  1982-07       Impact factor: 4.013

Review 4.  High-performance liquid chromatography of nucleotides, nucleosides and bases.

Authors:  M Zakaria; P R Brown
Journal:  J Chromatogr       Date:  1981-12-11

5.  Quantitative high-performance liquid chromatography of nucleosides and bases in human plasma.

Authors:  G A Taylor; P J Dady; K R Harrap
Journal:  J Chromatogr       Date:  1980-10-10

6.  HPLC analysis of aromatic amino acids, nucleosides, and bases in plasma of acute lymphocytic leukemia on chemotherapy.

Authors:  M Zakaria; P R Brown; M P Farnes; B E Barker
Journal:  Clin Chim Acta       Date:  1982-11-24       Impact factor: 3.786

7.  Thymidine transport in the central nervous system.

Authors:  R Spector
Journal:  J Neurochem       Date:  1980-11       Impact factor: 5.372

8.  Differences in deoxycytidine metabolism in mouse and rat.

Authors:  T S Chan; B D Lakhchaura; T F Hsu
Journal:  Biochem J       Date:  1983-02-15       Impact factor: 3.857

9.  High-performance liquid chromatographic methods for base and nucleoside analysis in extracellular fluids and in cells.

Authors:  R J Simmonds; R A Harkness
Journal:  J Chromatogr       Date:  1981-12-11

10.  Studies on alkaline phosphatase. Inhibition by phosphate derivatives and the substrate specificity.

Authors:  H N Fernley; P G Walker
Journal:  Biochem J       Date:  1967-09       Impact factor: 3.857

View more
  17 in total

1.  De Novo Guanine Biosynthesis but Not the Riboswitch-Regulated Purine Salvage Pathway Is Required for Staphylococcus aureus Infection In Vivo.

Authors:  Eric M Kofoed; Donghong Yan; Anand K Katakam; Mike Reichelt; Baiwei Lin; Janice Kim; Summer Park; Shailesh V Date; Ian R Monk; Min Xu; Cary D Austin; Till Maurer; Man-Wah Tan
Journal:  J Bacteriol       Date:  2016-06-27       Impact factor: 3.490

2.  CSF xanthine, homovanillic acid, and their ratio as biomarkers of Parkinson's disease.

Authors:  Peter LeWitt; Lonni Schultz; Peggy Auinger; Mei Lu
Journal:  Brain Res       Date:  2011-07-01       Impact factor: 3.252

3.  GMP Synthase Is Required for Virulence Factor Production and Infection by Cryptococcus neoformans.

Authors:  Jessica L Chitty; Tayla L Tatzenko; Simon J Williams; Y Q Andre E Koh; Elizabeth C Corfield; Mark S Butler; Avril A B Robertson; Matthew A Cooper; Ulrike Kappler; Bostjan Kobe; James A Fraser
Journal:  J Biol Chem       Date:  2017-01-06       Impact factor: 5.157

Review 4.  PRPS1 mutations: four distinct syndromes and potential treatment.

Authors:  Arjan P M de Brouwer; Hans van Bokhoven; Sander B Nabuurs; Willem Frans Arts; John Christodoulou; John Duley
Journal:  Am J Hum Genet       Date:  2010-04-09       Impact factor: 11.025

5.  Individual variability in human blood metabolites identifies age-related differences.

Authors:  Romanas Chaleckis; Itsuo Murakami; Junko Takada; Hiroshi Kondoh; Mitsuhiro Yanagida
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-28       Impact factor: 11.205

Review 6.  Purine import into malaria parasites as a target for antimalarial drug development.

Authors:  I J Frame; Roman Deniskin; Avish Arora; Myles H Akabas
Journal:  Ann N Y Acad Sci       Date:  2014-11-25       Impact factor: 5.691

7.  Cryptococcus neoformans ADS lyase is an enzyme essential for virulence whose crystal structure reveals features exploitable in antifungal drug design.

Authors:  Jessica L Chitty; Kirsten L Blake; Ross D Blundell; Y Q Andre E Koh; Merinda Thompson; Avril A B Robertson; Mark S Butler; Matthew A Cooper; Ulrike Kappler; Simon J Williams; Bostjan Kobe; James A Fraser
Journal:  J Biol Chem       Date:  2017-05-30       Impact factor: 5.157

8.  Hypoxanthine transport through the blood-brain barrier.

Authors:  R Spector
Journal:  Neurochem Res       Date:  1987-09       Impact factor: 3.996

9.  Cloning and expression of the hypoxanthine-guanine phosphoribosyltransferase gene from Trypanosoma brucei.

Authors:  T E Allen; B Ullman
Journal:  Nucleic Acids Res       Date:  1993-11-25       Impact factor: 16.971

10.  Alterations in cerebrospinal fluid uridine, hypoxanthine, and xanthine in head-injured patients.

Authors:  R A Mueller; M J Rosner; J N Ghia; S K Powers; E R Kafer; R D Hunt
Journal:  Cell Mol Neurobiol       Date:  1988-06       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.